Erste Asset Management GmbH boosted its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2,213.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 23,130 shares of the exchange traded fund’s stock after purchasing an additional 22,130 shares during the quarter. Erste Asset Management GmbH’s holdings in SPDR S&P Biotech ETF were worth $2,820,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Legacy Wealth Managment LLC ID purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $32,000. Greykasell Wealth Strategies Inc. purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $35,000. Ballast Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $36,000. Creative Financial Designs Inc. ADV purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $39,000. Finally, MCF Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $46,000.
SPDR S&P Biotech ETF Stock Performance
XBI opened at $131.38 on Wednesday. The business’s fifty day moving average is $132.23 and its two-hundred day moving average is $126.86. The company has a market cap of $8.38 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a one year low of $80.90 and a one year high of $139.19.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
